These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22388732)

  • 1. Gene therapy for cisplatin-induced ototoxicity: a systematic review of in vitro and experimental animal studies.
    Waissbluth S; Pitaro J; Daniel SJ
    Otol Neurotol; 2012 Apr; 33(3):302-10. PubMed ID: 22388732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against cisplatin-induced ototoxicity by adeno-associated virus-mediated delivery of the X-linked inhibitor of apoptosis protein is not dependent on caspase inhibition.
    Chan DK; Lieberman DM; Musatov S; Goldfein JA; Selesnick SH; Kaplitt MG
    Otol Neurotol; 2007 Apr; 28(3):417-25. PubMed ID: 17211286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
    Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
    Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are intratympanic injections of N-acetylcysteine and methylprednisolone protective against Cisplatin-induced ototoxicity?
    Saliba I; El Fata F; Ouelette V; Robitaille Y
    J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):236-43. PubMed ID: 20470667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of protective agents against cisplatin ototoxicity.
    Rybak LP; Husain K; Morris C; Whitworth C; Somani S
    Am J Otol; 2000 Jul; 21(4):513-20. PubMed ID: 10912697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals.
    Sockalingam R; Freeman S; Cherny TL; Sohmer H
    Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in Otos is associated with cisplatin-induced ototoxicity.
    Spracklen TF; Whitehorn H; Vorster AA; Ramma L; Dalvie S; Ramesar RS
    Pharmacogenomics; 2014 Sep; 15(13):1667-76. PubMed ID: 25410892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic vulnerability to cisplatin ototoxicity: a systematic review.
    Tserga E; Nandwani T; Edvall NK; Bulla J; Patel P; Canlon B; Cederroth CR; Baguley DM
    Sci Rep; 2019 Mar; 9(1):3455. PubMed ID: 30837596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
    Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
    Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-Induced Ototoxicity and the Effects of Intratympanic Diltiazem in a Mouse Model.
    Naples JG; Parham K
    Otolaryngol Head Neck Surg; 2016 Jan; 154(1):144-9. PubMed ID: 26419839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin alleviates cisplatin-induced ototoxicity in vivo.
    Fang B; Xiao H
    Biochem Biophys Res Commun; 2014 Jun; 448(4):443-7. PubMed ID: 24796670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA-mediated knock-down of NOX3: therapy for hearing loss?
    Rybak LP; Mukherjea D; Jajoo S; Kaur T; Ramkumar V
    Cell Mol Life Sci; 2012 Jul; 69(14):2429-34. PubMed ID: 22562580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.
    Riedemann L; Lanvers C; Deuster D; Peters U; Boos J; Jürgens H; am Zehnhoff-Dinnesen A
    Pharmacogenomics J; 2008 Feb; 8(1):23-8. PubMed ID: 17457342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo effects of lutein against cisplatin-induced ototoxicity.
    Roldán-Fidalgo A; Martín Saldaña S; Trinidad A; Olmedilla-Alonso B; Rodríguez-Valiente A; García-Berrocal JR; Ramírez-Camacho R
    Exp Toxicol Pathol; 2016 Apr; 68(4):197-204. PubMed ID: 26850526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-Induced Ototoxicity: Updates on Molecular Targets.
    Gentilin E; Simoni E; Candito M; Cazzador D; Astolfi L
    Trends Mol Med; 2019 Dec; 25(12):1123-1132. PubMed ID: 31473143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of cisplatin ototoxicity and progress in otoprotection.
    Rybak LP
    Curr Opin Otolaryngol Head Neck Surg; 2007 Oct; 15(5):364-9. PubMed ID: 17823555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and restoration of hearing loss associated with the use of cisplatin.
    Chirtes F; Albu S
    Biomed Res Int; 2014; 2014():925485. PubMed ID: 25140325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS.
    Li G; Liu W; Frenz D
    Neurotoxicology; 2006 Jan; 27(1):22-30. PubMed ID: 16125245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Effect of Korean Red Ginseng on Cisplatin Ototoxicity: Is It Effective Enough?
    Olgun Y; Kırkım G; Altun Z; Aktaş S; Kolatan E; Kiray M; Bağrıyanık A; Olgun A; Çakır Kızmazoğlu D; Özoğul C; Ellidokuz H; Erçetin P; Şerbetçioğlu B; Yılmaz O; Güneri EA
    J Int Adv Otol; 2016 Aug; 12(2):177-183. PubMed ID: 27487360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity.
    Gunes D; Kirkim G; Kolatan E; Guneri EA; Ozogul C; Altun Z; Serbetcioglu B; Yilmaz O; Aktas S; Mutafoglu K; Tufekci O; Erbayraktar Z; Olgun N
    Chemotherapy; 2011; 57(3):186-94. PubMed ID: 21525749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.